Alzheimer’s Drug May Benefit Some Patients, New Data Shows

The drug, lecanemab, made by Eisai and Biogen, also carried risks of brain swelling and bleeding and should be studied further, a report of the findings said.

from NYT > Health https://ift.tt/KcRADeV
https://ift.tt/qYILKcZ
via IFTTT